Jordan A. Headen

Jordan A. Headen

Auto-generated profile, based on publicly available information

Jordan A. Headen

Department of Biological Sciences, University of South Carolina; Columbia, SC 29204 USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Neuroscience Research
Verified
Journal Article
Closed access
LELora A. Estera
Lora A. Estera
SWSam P. Walsh
Sam P. Walsh
JHJordan A. Headen
Jordan A. Headen
RWRachel E. Williamson
Rachel E. Williamson
AKAshley L. Kalinski
Ashley L. Kalinski

4 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
KRKatelyn Rygel
Katelyn Rygel
KCKareem Chambers
Kareem Chambers
BYBrian Yoon
Brian Yoon
MAManasi Agrawal
Manasi Agrawal
SBSamantha A. Bailey
Samantha A. Bailey
KWKristy Welshhans
Kristy Welshhans
Down syndrome is a neurodevelopmental disorder caused by the trisomy of human chromosome 21 (T21). Down syndrome is associated with a wide range of variable clinical features, including congenital heart defects and slow wound healing; however, intellectual disability is ubiquitous and results, in part, from altered neuronal connectivity. Here, we used three sets of control and T21 human fibroblasts and one set of human induced pluripotent stem cell (hiPSC)-derived cortical neurons to examine whether changes in cellular morphology and motility are consistent across cell types in Down syndrome and to elucidate the underlying mechanisms. We found that fibroblast morphology is dysregulated in all T21 fibroblast lines. Using a transwell migration assay, cellular migration is decreased in two of the three T21 fibroblast lines. T21 hiPSC-derived cortical neurons also exhibit morphological defects, including a decrease in the length of the longest neurite and growth cone area. Because of these significant changes in morphology and motility in T21 cells, we examined proteins in the focal adhesion complex, which links the intracellular cytoskeleton to the extracellular matrix and directly controls these processes. Multiple proteins in the adhesion complex, including paxillin, vinculin, talin, and RACK1, are dysregulated in T21 fibroblasts and hiPSC-derived neurons, but these changes have high inter-individual variability. Taken together, these findings suggest that altered cellular morphology and motility are conserved features of Down syndrome that arise through heterogeneous alterations in adhesion networks. Thus, this work significantly contributes to the recent literature highlighting the need for personalized medicine in Down syndrome.

28 August 2026 in Science Advances
Verified
Journal Article
Open access
CBCourtney Buchanan
Courtney Buchanan
JLJinyoung Lee
Jinyoung Lee
SMSamaneh Matoo
Samaneh Matoo
JHJordan A. Headen
Jordan A. Headen
MHMarie-Claire Honoree
Marie-Claire Honoree
JTJeffery Lewis Twiss
Jeffery Lewis Twiss
Injured axons synthesize the RNA Binding Protein KHSRP that promotes mRNA decay and slows nerve regeneration. Axotomy-induced increase in axoplasmic Ca 2+ activates axonal Khsrp translation, and while axonal Ca 2+ returns to pre-injury levels within 16 hours post-axotomy, axonal KHSRP remains elevated. Alternating translation of Reg3a and Khsrp sustains KHSRP levels in regenerating axons. Axonal Reg3a mRNA and protein increase proximal to the injury site days after sciatic nerve crush. REG3A stimulates ER Ca 2+ release in axons to activate PERK, increase eIF2α phosphorylation, and increase Khsrp translation. Axoplasmic Ca 2+ slowly oscillates in growth cones of cultured neurons and Reg3a depletion attenuates growth cone Ca 2+ oscillations, decreases KHSRP synthesis and reduces axonal retractive events in cultured neurons, and accelerates peripheral nerve regeneration in vivo. Thus, REG3A regulation of axonal KHSRP synthesis provides a signaling loop that decelerates axon growth through localized mRNA translation.